News In Brief
This article was originally published in The Gray Sheet
Joint Commission urges caution in imaging
You may also be interested in...
New CEOs at Nephros and Crescent Diagnostics, plus a new name and CEO for transcatheter valve accessory company. More people briefs.
Cyberonics aims to submit a repair plan to FDA by April 2012 for its AspireHC vagus nerve stimulation therapy generator for epilepsy treatment following a recall of the device announced Aug. 15.
Edwards Lifesciences’ Sapien transcatheter aortic valve met widespread expectations last week by gaining support for FDA approval from an agency advisory panel, but the experts urged FDA and Edwards to proceed cautiously.